Tokyo Tape
Sign in
← Muromachi Chemicals

Quarterly report · Q2

4885.TEDINET S100SLIK
Period2023-06-01 → 2023-11-30
Filed2024-01-12
StandardJapan GAAP
ConsolidatedNo
Data checks12 of 12 passed
Key figures · 51
MetricValuePeriodScopeSource row
Revenue¥2.9bn2023-06-01 → 2023-11-30StandaloneNet sales
Revenue¥6.3bn2022-06-01 → 2023-05-31StandaloneNet sales (5-year summary)
Revenue¥3.1bn2022-06-01 → 2022-11-30StandaloneNet sales
Operating income¥115m2023-06-01 → 2023-11-30StandaloneOperating income
Operating income¥225m2022-06-01 → 2022-11-30StandaloneOperating income
Ordinary income¥110m2023-06-01 → 2023-11-30StandaloneOrdinary income
Ordinary income¥351m2022-06-01 → 2023-05-31StandaloneOrdinary income loss (5-year summary)
Ordinary income¥208m2022-06-01 → 2022-11-30StandaloneOrdinary income
Profit before tax¥145m2023-06-01 → 2023-11-30StandaloneIncome before income taxes
Profit before tax¥208m2022-06-01 → 2022-11-30StandaloneIncome before income taxes
Net income¥93m2023-06-01 → 2023-11-30StandaloneProfit loss
Net income¥256m2022-06-01 → 2023-05-31StandaloneNet income loss (5-year summary)
Net income¥149m2022-06-01 → 2022-11-30StandaloneProfit loss
Total assets¥5.1bnat 2023-11-30StandaloneAssets
Total assets¥4.9bnat 2023-05-31StandaloneAssets
Total assets¥5.0bnat 2022-11-30StandaloneTotal assets (5-year summary)
Total liabilities¥3.1bnat 2023-11-30StandaloneLiabilities
Total liabilities¥3.0bnat 2023-05-31StandaloneLiabilities
Net assets / equity¥2.0bnat 2023-11-30StandaloneNet assets
Net assets / equity¥1.9bnat 2023-05-31StandaloneNet assets
Net assets / equity¥1.8bnat 2022-11-30StandaloneNet assets (5-year summary)
Cash and deposits¥1.1bnat 2023-11-30StandaloneCash and deposits
Cash and deposits¥853mat 2023-05-31StandaloneCash and deposits
Cash & equivalents¥1.1bnat 2023-11-30StandaloneCash and cash equivalents
Cash & equivalents¥853mat 2023-05-31StandaloneCash and cash equivalents
Cash & equivalents¥765mat 2022-11-30StandaloneCash and cash equivalents
Cash & equivalents¥865mat 2022-05-31dStandaloneCash and cash equivalents
Operating cash flow¥143m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in operating activities
Operating cash flow¥317m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow−¥58m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in operating activities
Investing cash flow−¥115m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in investment activities
Investing cash flow−¥162m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥69m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in investment activities
Financing cash flow¥185m2023-06-01 → 2023-11-30StandaloneNet cash provided by used in financing activities
Financing cash flow−¥172m2022-06-01 → 2023-05-31StandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow¥28m2022-06-01 → 2022-11-30StandaloneNet cash provided by used in financing activities
EPS (basic)¥23.632023-06-01 → 2023-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥17.852023-09-01 → 2023-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥67.942022-06-01 → 2023-05-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥39.922022-06-01 → 2022-11-30StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥16.82022-09-01 → 2022-11-30dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥23.162023-06-01 → 2023-11-30StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥64.122022-06-01 → 2023-05-31StandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥38.622022-06-01 → 2022-11-30StandaloneDiluted earnings per share (5-year summary)
Dividend per share¥192022-06-01 → 2023-05-31StandaloneDividend paid per share (5-year summary)
Equity ratio38.9%at 2023-11-30StandaloneEquity to asset ratio (5-year summary)
Equity ratio38.7%at 2023-05-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio35.8%at 2022-11-30StandaloneEquity to asset ratio (5-year summary)
Shares issued4,095,500at 2023-11-30StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2023-05-31StandaloneTotal number of issued shares (5-year summary)
Shares issued4,095,500at 2022-11-30StandaloneTotal number of issued shares (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 30
SegmentItemPeriodValue
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.0bn
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥55m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥379m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2023-06-01 → 2023-11-30−¥28m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2023-06-01 → 2023-11-30¥1.5bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2023-06-01 → 2023-11-30¥198m
—segment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
—segment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
—segment totalsegment profit2023-06-01 → 2023-11-30¥115m
Total Of Reportable Segments And Otherssegment totalrevenue2023-06-01 → 2023-11-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalrevenue external2023-06-01 → 2023-11-30¥2.9bn
Total Of Reportable Segments And Otherssegment totalsegment profit2023-06-01 → 2023-11-30¥115m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥965m
jpcrp040300-q2r_E36350-000Chemical Products Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥20m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥377m
jpcrp040300-q2r_E36350-000Healthy Food Businessreportable segmentsegment profit2022-06-01 → 2022-11-30−¥39m
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentrevenue external2022-06-01 → 2022-11-30¥1.8bn
jpcrp040300-q2r_E36350-000Pharmaceutical Businessreportable segmentsegment profit2022-06-01 → 2022-11-30¥284m
—segment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
—segment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
—segment totalsegment profit2022-06-01 → 2022-11-30¥225m
Total Of Reportable Segments And Otherssegment totalrevenue2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalrevenue external2022-06-01 → 2022-11-30¥3.1bn
Total Of Reportable Segments And Otherssegment totalsegment profit2022-06-01 → 2022-11-30¥225m

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 517
ItemContextValueUnit
Short term loans payableCurrentQuarterInstant_NonConsolidatedMember100000000JPY
Current portion of long term loans payablePrior1YearInstant_NonConsolidatedMember195880000JPY
Current portion of long term loans payableCurrentQuarterInstant_NonConsolidatedMember404556000JPY
Income taxes payablePrior1YearInstant_NonConsolidatedMember40528000JPY
Income taxes payableCurrentQuarterInstant_NonConsolidatedMember20270000JPY
Provision for bonusesPrior1YearInstant_NonConsolidatedMember191125000JPY
Provision for bonusesCurrentQuarterInstant_NonConsolidatedMember198657000JPY
Other clPrior1YearInstant_NonConsolidatedMember303691000JPY
Other clCurrentQuarterInstant_NonConsolidatedMember300872000JPY
Current liabilitiesPrior1YearInstant_NonConsolidatedMember2055535000JPY
Current liabilitiesCurrentQuarterInstant_NonConsolidatedMember1692292000JPY
Long term loans payablePrior1YearInstant_NonConsolidatedMember872200000JPY
Long term loans payableCurrentQuarterInstant_NonConsolidatedMember1319160000JPY
Provision for retirement benefitsPrior1YearInstant_NonConsolidatedMember20048000JPY
Provision for retirement benefitsCurrentQuarterInstant_NonConsolidatedMember23857000JPY
Asset retirement obligations nclPrior1YearInstant_NonConsolidatedMember26227000JPY
Asset retirement obligations nclCurrentQuarterInstant_NonConsolidatedMember26227000JPY
Long term accounts payable otherPrior1YearInstant_NonConsolidatedMember56845000JPY
Long term accounts payable otherCurrentQuarterInstant_NonConsolidatedMember37405000JPY
Other nclPrior1YearInstant_NonConsolidatedMember2225000JPY
Other nclCurrentQuarterInstant_NonConsolidatedMember5369000JPY
Noncurrent liabilitiesPrior1YearInstant_NonConsolidatedMember977546000JPY
Noncurrent liabilitiesCurrentQuarterInstant_NonConsolidatedMember1412019000JPY
LiabilitiesPrior1YearInstant_NonConsolidatedMember3033082000JPY
LiabilitiesCurrentQuarterInstant_NonConsolidatedMember3104311000JPY
Capital stockPrior1YearInstant_NonConsolidatedMember143172000JPY
Capital stockCurrentQuarterInstant_NonConsolidatedMember143172000JPY
Capital surplusPrior1YearInstant_NonConsolidatedMember665869000JPY
Capital surplusCurrentQuarterInstant_NonConsolidatedMember672447000JPY
Retained earningsPrior1YearInstant_NonConsolidatedMember1137420000JPY
Retained earningsCurrentQuarterInstant_NonConsolidatedMember1155980000JPY
Treasury stockPrior1YearInstant_NonConsolidatedMember-49944000JPY
Treasury stockCurrentQuarterInstant_NonConsolidatedMember-39217000JPY
Deposit for subscriptions to treasury stockPrior1YearInstant_NonConsolidatedMember223000JPY
Deposit for subscriptions to treasury stockCurrentQuarterInstant_NonConsolidatedMember－JPY
Shareholders equityPrior1YearInstant_NonConsolidatedMember1896740000JPY
Shareholders equityCurrentQuarterInstant_NonConsolidatedMember1932383000JPY
Valuation difference on available for sale securitiesPrior1YearInstant_NonConsolidatedMember18488000JPY
Valuation difference on available for sale securitiesCurrentQuarterInstant_NonConsolidatedMember45196000JPY
Valuation and translation adjustmentsPrior1YearInstant_NonConsolidatedMember18488000JPY
Valuation and translation adjustmentsCurrentQuarterInstant_NonConsolidatedMember45196000JPY
Net assetsPrior1YearInstant_NonConsolidatedMember1915229000JPY
Net assetsCurrentQuarterInstant_NonConsolidatedMember1977580000JPY
Liabilities and net assetsPrior1YearInstant_NonConsolidatedMember4948311000JPY
Liabilities and net assetsCurrentQuarterInstant_NonConsolidatedMember5081891000JPY
Net salesPrior1YTDDuration_NonConsolidatedMember3121245000JPY
Net salesCurrentYTDDuration_NonConsolidatedMember2912325000JPY
Cost of salesPrior1YTDDuration_NonConsolidatedMember2226884000JPY
Cost of salesCurrentYTDDuration_NonConsolidatedMember2084058000JPY
Gross profitPrior1YTDDuration_NonConsolidatedMember894360000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identitynon_consolidated 2023-05-31pass
balance sheet identitynon_consolidated 2023-11-30pass
dei present pass
period resolution pass
statement vs summary · net assetsnon_consolidated 2023-05-31pass
statement vs summary · net assetsnon_consolidated 2023-11-30pass
statement vs summary · operating cash flownon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · operating cash flownon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · revenuenon_consolidated 2022-06-01/2022-11-30pass
statement vs summary · revenuenon_consolidated 2023-06-01/2023-11-30pass
statement vs summary · total assetsnon_consolidated 2023-05-31pass
statement vs summary · total assetsnon_consolidated 2023-11-30pass